Use of human chorionic gonadotropin as an immune-potentiating antiviral agent
OwnerPamela Jo Harrisinventor
Life of this patent
Estimating the term…
Abstract
Prophylaxis against viral infections, as well as treatment for individuals infected with a virus, can be achieved through the administration of human chorionic gonadotropin (HCG). Exemplary of the viral infections that are amenable to the use of HCG in this regard include those caused by HIV-1, Kaposi's sarcoma herpes virus, molluscipoxvirus and cytomegalovirus. In addition, HCG can be used as a neonatal immune booster via administration to a baby at delivery and, optionally, for the first several months of life, until the infantile immune system matures, in order to prevent HIV transmission and control any low-level viremia, as well as to protect against various other viruses, such as herpes viruses and oncogenic viruses.
Claims11
A method of treating or reducing the likelihood of a viral infection in a human patient suffering or at risk for suffering said infection, comprising (A) administering to said subject a clinically effective amount of human chorionic gonadotropin (HCG), wherein said effective amount is at least 10,000 IU, and then (B) monitoring said patient for parameters of said infection.
Human chorionic gonadotropin hormone in a therapeutic, sustained-release form.
Dependencies are inferred from the claim text.